| # | Drug | Count |
|---|---|---|
| 0 | INSULIN GLARGINE | 118 |
| 1 | INSULIN LISPRO | 87 |
| 2 | INSULIN HUMAN | 72 |
| 3 | INSULIN ASPART | 39 |
| 4 | INSULIN | 33 |
| 5 | ASPIRIN | 24 |
| 6 | ASPIRIN 325 MG | 24 |
| 7 | ASPIRIN 81 MG | 24 |
| 8 | METFORMIN | 24 |
| 9 | FUROSEMIDE | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLUCAGON | 12 | 0.0028 |
| 1 | INSULIN HUMAN | 72 | 0.0018 |
| 2 | INSULIN GLULISINE | 18 | 0.0018 |
| 3 | HUMAN INSULIN | 9 | 0.0013 |
| 4 | INSULIN ASPART INJECTION | 2 | 0.0007 |
| 5 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 2 | 0.0007 |
| 6 | INSULIN LISPRO | 87 | 0.0006 |
| 7 | INSULIN ASPART | 39 | 0.0006 |
| 8 | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 2 | 0.0006 |
| 9 | CALCIUM CARBONATE, SIMETHICONE | 3 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 217 |
| 1 | Insulin [EPC] | 78 |
| 2 | GLP-1 Receptor Agonist [EPC] | 36 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 28 |
| 4 | Loop Diuretic [EPC] | 27 |
| 5 | Sulfonylurea [EPC] | 27 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 26 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 24 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 15 |
| 9 | Thiazide Diuretic [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antihypoglycemic Agent [EPC] | 12 | 0.0028 |
| 1 | Insulin [EPC] | 78 | 0.0017 |
| 2 | Insulin Analog [EPC] | 217 | 0.0005 |
| 3 | Calcitonin [EPC] | 1 | 0.0003 |
| 4 | Vitamin D2 Analog [EPC] | 2 | 0.0003 |
| 5 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 6 | Glinide [EPC] | 2 | 0.0002 |
| 7 | Sulfonylurea [EPC] | 27 | 0.0002 |
| 8 | Paramagnetic Contrast Agent [EPC] | 1 | 0.0002 |
| 9 | Progestin Antagonist [EPC] | 1 | 0.0002 |